DK0502928T3 - Fremgangsmåder til detektion af collagennedbrydning in vivo - Google Patents

Fremgangsmåder til detektion af collagennedbrydning in vivo

Info

Publication number
DK0502928T3
DK0502928T3 DK91900109.9T DK91900109T DK0502928T3 DK 0502928 T3 DK0502928 T3 DK 0502928T3 DK 91900109 T DK91900109 T DK 91900109T DK 0502928 T3 DK0502928 T3 DK 0502928T3
Authority
DK
Denmark
Prior art keywords
vivo
methods
collagen degradation
detecting collagen
detecting
Prior art date
Application number
DK91900109.9T
Other languages
Danish (da)
English (en)
Inventor
David R Eyre
Original Assignee
Washington Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27034100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0502928(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/444,881 external-priority patent/US5140103A/en
Application filed by Washington Res Found filed Critical Washington Res Found
Application granted granted Critical
Publication of DK0502928T3 publication Critical patent/DK0502928T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91900109.9T 1989-12-01 1990-11-30 Fremgangsmåder til detektion af collagennedbrydning in vivo DK0502928T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/444,881 US5140103A (en) 1987-11-06 1989-12-01 Peptide fragments containing HP and LP cross-links
US07/614,719 US5300434A (en) 1987-11-06 1990-11-21 Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide

Publications (1)

Publication Number Publication Date
DK0502928T3 true DK0502928T3 (da) 1996-02-19

Family

ID=27034100

Family Applications (3)

Application Number Title Priority Date Filing Date
DK91900109.9T DK0502928T3 (da) 1989-12-01 1990-11-30 Fremgangsmåder til detektion af collagennedbrydning in vivo
DK95201148T DK0682256T3 (da) 1989-12-01 1990-11-30 Fremgangsmåde til en vivo-påvisning af collagennedbrydning
DK95201176T DK0682257T3 (da) 1989-12-01 1990-11-30 Fremgangsmåder til detektion af collagennedbrydning in vivo

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK95201148T DK0682256T3 (da) 1989-12-01 1990-11-30 Fremgangsmåde til en vivo-påvisning af collagennedbrydning
DK95201176T DK0682257T3 (da) 1989-12-01 1990-11-30 Fremgangsmåder til detektion af collagennedbrydning in vivo

Country Status (13)

Country Link
US (5) US5300434A (ja)
EP (6) EP1632502A1 (ja)
JP (6) JP2782017B2 (ja)
AT (3) ATE133790T1 (ja)
AU (1) AU645049B2 (ja)
DE (4) DE502928T1 (ja)
DK (3) DK0502928T3 (ja)
ES (2) ES2061422T3 (ja)
GR (3) GR940300047T1 (ja)
IE (1) IE65280B1 (ja)
NO (1) NO309483B1 (ja)
RU (1) RU2139541C1 (ja)
WO (1) WO1991008478A2 (ja)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2551939B1 (fr) * 1983-09-14 1985-10-11 Cit Alcatel Dispositif de transfert et de traitement de voies de donnees ou de signalisation d'un ensemble de lignes multiplex
US6027903A (en) * 1987-11-06 2000-02-22 Washington Research Foundation Kit for detecting analyte indicative of type I collagen resorption in vivo
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5962639A (en) * 1987-11-06 1999-10-05 Washington Research Foundation Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US6153732A (en) * 1987-11-06 2000-11-28 Washington Research Foundation Kit for detecting analyte indicative of type II collagen resorption in vivo
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
US5350855A (en) * 1992-09-30 1994-09-27 Metra Biosystems, Inc. Derivatized D-acyl pyridinium reagent
US6132976A (en) * 1992-12-04 2000-10-17 Shriners Hospitals For Children Immunoassays for the measurement of collagen denaturation and cleavage in cartilage
AU5851494A (en) * 1992-12-17 1994-07-04 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
JPH08505149A (ja) * 1992-12-28 1996-06-04 ジェイ． ベイリンク，デビッド 骨再吸収検定法
DK104093D0 (da) † 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
US6110689A (en) * 1994-01-21 2000-08-29 Osteometer A/S Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
US5516699A (en) * 1994-02-16 1996-05-14 Institute Of Molecular Biology, Inc. Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity
GB9506050D0 (en) 1995-03-24 1995-05-10 Osteometer A S Assaying collagen fragments in body fluids
ES2154739T3 (es) 1994-10-17 2001-04-16 Osteometer Biotech As Estimacion del modelo de fragmentacion del colageno en fluidos corporales y el diagnostico de trastornos asociados con el metabolismo del colageno.
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
DE19518232A1 (de) * 1995-05-12 1996-11-14 Ruediger Dr Schade Aviäre, vitelline, gegen Stützgewebe gerichtete Antikörper
US5750647A (en) * 1995-05-19 1998-05-12 Washington Research Foundation Synthetic peptide analogs of NTx
US6107047A (en) * 1996-03-21 2000-08-22 Osteometer Biotech A/S Assaying protein fragments in body fluids
ATE309271T1 (de) * 1996-05-16 2005-11-15 Texas A & M Univ Sys Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
GB9617616D0 (en) 1996-08-22 1996-10-02 Osteometer Biotech As Assaying protein fragments in body fluids
JP3913787B2 (ja) 1996-12-09 2007-05-09 オステオメーター・ビオテク・エー／エス Ｉ型コラーゲン断片のサンドウイッチ測定法
US5834610A (en) * 1997-05-06 1998-11-10 Johnson; Gary M. Conversion of pyridinoline to deoxypyridinoline
US5989925A (en) * 1997-06-27 1999-11-23 Serex, Inc. Antibody to and assay for peptide linked-pyridinoline as indicator of bone resorption level
WO1999006840A1 (en) * 1997-07-31 1999-02-11 Metra Biosystems, Inc. Collagen-peptide assay method
US6117646A (en) * 1997-09-22 2000-09-12 Osteometer Biotech A/S Assaying protein fragments in body fluids
US6030792A (en) * 1997-11-13 2000-02-29 Pfizer Inc Assays for measurement of protein fragments in biological media
WO2000079284A1 (en) * 1999-06-17 2000-12-28 Washington Research Foundation Cartilage resorption assays
EP1088228B1 (en) 1998-06-19 2005-08-24 Washington Research Foundation Cartilage resorption assays
US6916903B2 (en) * 1998-06-19 2005-07-12 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
US6348320B1 (en) 1998-06-19 2002-02-19 Washington Research Foundation Cartilage resorption assays measuring type II collagen fragments
US6602980B1 (en) 1998-06-19 2003-08-05 Washington Research Foundation Collagen type III synthetic peptides for collagen resorption assays
ES2333845T3 (es) * 1999-01-06 2010-03-02 University Of Southern California Metodo y composicion para la inhibicion de la angiogenesis.
CA2424431A1 (en) 2000-10-03 2002-04-11 Rowett Research Institute Method of assaying pyrrole-containing biological compounds
WO2002074324A1 (en) * 2001-03-15 2002-09-26 The Texas A & M University System Collagen-binding adhesin from staphylococcus epidermidis and method of use
WO2006020231A2 (en) * 2004-07-21 2006-02-23 Medtronic, Inc. Medical devices and methods for reducing localized fibrosis
US20060030538A1 (en) * 2004-07-21 2006-02-09 Medtronic, Inc. Methods for reducing or preventing localized fibrosis using SiRNA
CA2626804A1 (en) 2005-11-01 2007-08-09 Abbott Biotechnology Ltd. Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
JP2007162988A (ja) * 2005-12-12 2007-06-28 Sanden Corp 蒸気圧縮式冷凍サイクル
WO2008156865A2 (en) * 2007-06-20 2008-12-24 Schering Corporation Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
EP2538221A3 (en) * 2007-11-05 2013-04-24 Nordic Bioscience A/S Biochemical markers for CVD risk assessment
US9012160B2 (en) * 2008-06-16 2015-04-21 Abraham Amir Monitoring skin metabolism products for evaluating burn injury
WO2011034128A1 (ja) 2009-09-16 2011-03-24 塩野義製薬株式会社 コラーゲンネオエピトープ抗体
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
USRE49477E1 (en) 2012-04-20 2023-03-28 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
EP3387107B1 (en) 2015-12-11 2020-08-12 Spartan Bioscience Inc. Tube sealing system and methods for nucleic acid amplification
WO2023068248A1 (ja) * 2021-10-20 2023-04-27 積水メディカル株式会社 Ｉ型コラーゲン架橋ｎ－テロペプチドの免疫測定方法及び免疫測定キット、並びに抗体又はその抗体断片
WO2023068249A1 (ja) * 2021-10-20 2023-04-27 積水メディカル株式会社 Ｉ型コラーゲン架橋ｎ－テロペプチドの測定試薬、その調製方法、及びそれを用いた免疫測定方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6716836A (ja) * 1967-12-11 1969-06-13
JPS5164788A (ja) * 1974-12-03 1976-06-04 Orion Yakuhin Kogyo Kk Shodokuyomennometsukinhoho
US4094646A (en) * 1977-06-02 1978-06-13 The Baltimore Spice Company Rapid method of assaying collagen in meat and meat products
LU78457A1 (fr) * 1977-11-04 1979-06-13 Prayon Soc Procede de fabrication d'acide phosphorique
DE2816841A1 (de) * 1978-04-18 1979-10-31 Max Planck Gesellschaft Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii)
US4298593A (en) * 1979-08-21 1981-11-03 Abbott Laboratories Reagents and methods utilizing labeled Fab bound to antigens
US4371374A (en) * 1980-11-17 1983-02-01 The Rockefeller University Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine
DE3209149A1 (de) * 1982-03-13 1983-10-06 Hoechst Ag Verfahren zur gemeinsamen immunologischen bestimmung von prokollagen-peptid (typ iii) und prokollagen-peptid col 1 (typ iii) und verfahren zur herstellung von anti-prokollagen-peptid col 1 (typ iii)-serum
CA1229789A (en) * 1983-06-06 1987-12-01 David Baylink Polypeptides exhibiting skeletal growth factor activity
JPS60198156A (ja) * 1984-03-19 1985-10-07 凸版印刷株式会社 プラスチツク製品の殺菌方法
JPS60256457A (ja) * 1984-06-01 1985-12-18 大日本印刷株式会社 包装材料の殺菌方法
US4731326A (en) * 1984-06-04 1988-03-15 Ortho Diagnostic Systems Inc. Disease diagnosis by detection of shed normal tissue antigens
US4774227A (en) * 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
ES2063033T3 (es) * 1987-04-28 1995-01-01 Boehringer Mannheim Gmbh Empleo de igf-ii en el tratamiento de la enfermedades de los huesos.
GB2205643B (en) * 1987-05-08 1991-03-13 Farmos Group Limited Type iii collagen degradation assay
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5320970A (en) * 1987-11-06 1994-06-14 Washington Research Foundation Detection of collagen degradation in vivo
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8815174D0 (en) * 1988-06-25 1988-08-03 Rowett Research Inst Method of monitoring collagen degradation
WO1990004417A1 (en) * 1988-10-24 1990-05-03 Bruce Caterson Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
WO1990008195A1 (en) * 1989-01-13 1990-07-26 President And Fellows Of Harvard College Monoclonal antibody to human type ix collagen
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation

Also Published As

Publication number Publication date
EP0682257B1 (en) 1999-04-28
AU6889891A (en) 1991-06-26
DE69034170D1 (de) 2004-11-18
EP0682257A1 (en) 1995-11-15
DE69033082D1 (de) 1999-06-02
RU2139541C1 (ru) 1999-10-10
ATE179521T1 (de) 1999-05-15
WO1991008478A3 (en) 1991-11-28
IE904344A1 (en) 1991-06-05
JPH09113510A (ja) 1997-05-02
US5677198A (en) 1997-10-14
ES2061422T1 (es) 1994-12-16
NO922149L (no) 1992-07-29
JP2000050865A (ja) 2000-02-22
EP0502928B1 (en) 1996-01-31
DE69025199T2 (de) 1996-05-30
US5656439A (en) 1997-08-12
JPH10260183A (ja) 1998-09-29
ES2061422T3 (es) 1996-03-16
US5473052A (en) 1995-12-05
EP1632502A1 (en) 2006-03-08
ATE279730T1 (de) 2004-10-15
DE69034170T2 (de) 2006-03-02
NO309483B1 (no) 2001-02-05
GR940300047T1 (en) 1994-07-29
DK0682257T3 (da) 1999-11-08
EP0502928A1 (en) 1992-09-16
ATE133790T1 (de) 1996-02-15
JP2999416B2 (ja) 2000-01-17
US5576189A (en) 1996-11-19
US5300434A (en) 1994-04-05
DK0682256T3 (da) 2005-02-14
EP1560026A1 (en) 2005-08-03
JP2999444B2 (ja) 2000-01-17
NO922149D0 (no) 1992-05-29
JP2000055915A (ja) 2000-02-25
EP0682256B1 (en) 2004-10-13
IE65280B1 (en) 1995-10-18
JPH05502223A (ja) 1993-04-22
GR3030646T3 (en) 1999-10-29
JP2002139492A (ja) 2002-05-17
EP0890840A3 (en) 2000-05-17
JP3299941B2 (ja) 2002-07-08
GR3018852T3 (en) 1996-05-31
DE69025199D1 (de) 1996-03-14
ES2133656T3 (es) 1999-09-16
DE69033082T2 (de) 1999-09-30
JP2782017B2 (ja) 1998-07-30
EP0682256A1 (en) 1995-11-15
WO1991008478A2 (en) 1991-06-13
EP0890840A2 (en) 1999-01-13
DE502928T1 (de) 1994-08-18
AU645049B2 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
DK0682257T3 (da) Fremgangsmåder til detektion af collagennedbrydning in vivo
DE68918103T3 (de) Verfahren zur überwachung des kollagenabbaus.
ATE169739T1 (de) Verfahren zum nachweis des abbaus von typ-i- kollagen
DK0659275T3 (da) Analytisk testapparat med indbygget negativ og positiv kontrol
DE394296T1 (de) Urintest zur messung von knochenresorption.
ATE50646T1 (de) System zur bestimmung der konzentration von bestandteilen von koerperfluessigkeiten.
FI950507A (fi) Määritysmenetelmä proteiinin määrittämiseksi biologisesta näytteestä
DE69821246D1 (de) Testverfahren für collagenpeptid
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
BR9612475A (pt) Método de determinação do estado hepático de uma pessoa incluíndo um beneficiário para transplante de figado
DE69421619T2 (de) Phosphattest
DE29608735U1 (de) Sonde zur Messung von Niveaus von Flüssigkeiten, insbesondere Arbeitsflüssigkeiten in Behältern
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp
DE19980834T1 (de) Knorpel-Resorptionstests